Literature DB >> 7656537

Venous thromboembolism. Risk factors and prophylaxis.

F A Anderson1, H B Wheeler.   

Abstract

Most deaths from pulmonary embolism can be prevented by providing adequate prophylaxis for hospital patients who are at high risk for venous thromboembolism. Physicians, however, must be able to identify high-risk patients (including those with major trauma, hip or knee replacement, or pelvic fractures) and prescribe an appropriate prophylactic agent for each patient according to his or her level of risk. A number of prophylactic methods have been proven effective in the prevention of venous thromboembolism, including low-dose heparin, low-molecular-weight heparin, warfarin, graduated compression stockings, and intermittent pneumatic compression of the legs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7656537

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  12 in total

1.  Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery.SAGES position statement. Society of American Gastrointestinal Endoscopic Surgeons.

Authors: 
Journal:  Surg Endosc       Date:  1999-02       Impact factor: 4.584

2.  The AVAIL ME study: a multinational survey of VTE risk and prophylaxis.

Authors:  Ali T Taher; Joseph Aoun; Pascale Salameh
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  Study of clinical profile and management of patients with pulmonary embolism - single center study.

Authors:  S Calwin Davidsingh; Narayanan Srinivasan; P Balaji; U Kalaichelvan; Ajit Sankaradas Mullasari
Journal:  Indian Heart J       Date:  2014-02-01

Review 4.  Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?

Authors:  John Y C Tsang; James C Hogg
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

5.  Antithrombotic prophylaxis in the middle East.

Authors:  Samir Arnaout; Hanady R Samaha; Julien Succar; Imad Bou-Akl; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

6.  Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis.

Authors:  Gordan Srkalovic; Marte G Cameron; Steven R Deitcher; Kandice Kattke-Marchant; Mohamad A Hussein
Journal:  Int Semin Surg Oncol       Date:  2005-09-02

7.  Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study.

Authors:  Alhossain A Khalafallah; Brooke E Kirkby; Sophia Wong; Yi Chao Foong; Nishant Ranjan; James Luttrell; Ronnie Mathew; Charles M Chilvers; Emily Mauldon; Colin Sharp; Terry Hannan
Journal:  BMJ Open       Date:  2016-08-03       Impact factor: 2.692

8.  Clinical profile, management and outcome of pulmonary embolism in Shahid Gangalal National Heart Centre, Kathmandu, Nepal.

Authors:  Chandra Mani Adhikari; K C Bishal; Sobita Khadka
Journal:  Egypt Heart J       Date:  2017-06-27

Review 9.  Venous thromboembolism in head and neck cancer surgery.

Authors:  Faisal I Ahmad; Daniel R Clayburgh
Journal:  Cancers Head Neck       Date:  2016-11-01

10.  Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention.

Authors:  James Yip; David A Bruno; Charlotte Burmeister; Marwan Kazimi; Atsushi Yoshida; Marwan S Abouljoud; Gabriel T Schnickel
Journal:  Transplant Direct       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.